I BET on anti‐FGFR to fight cancer resistance

I BET on anti‐FGFR to fight cancer resistance

Graphical Abstract L. Altucci and R. Benedetti discuss the study by Chua et al (in this issue of EMBO Molecular Medicine), in which co‐targeting of FGFR signaling increases the responses of metastatic uveal melanoma to BET inhibitors.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:EMBO molecular medicine 2019-02, Vol.11 (2), p.1-n/a
Hauptverfasser: Benedetti, Rosaria, Altucci, Lucia
Format: Artikel
Sprache:eng
Schlagworte:
Cancer
Cell culture
Clinical trials
EMBO03
Fibroblast Growth Factor 2
Fibroblast growth factor receptors
Genomes
Humans
Kinases
Liver
Medical prognosis
Medical research
Melanoma
Metastases
Metastasis
News & Views
Ovarian cancer
Patients
Tumors
Uveal Neoplasms
Views
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Graphical Abstract L. Altucci and R. Benedetti discuss the study by Chua et al (in this issue of EMBO Molecular Medicine), in which co‐targeting of FGFR signaling increases the responses of metastatic uveal melanoma to BET inhibitors.
ISSN:1757-4676
1757-4684
DOI:10.15252/emmm.201810116